The FDA has authorized a second booster dose of either the Moderna or Pfizer-BioNtech COVID-19 vaccine for older people and certain immunocompromised individuals. | via NPR
As immunity wanes fom the first booster, the FDA has now authorized a second shot for people 50 and older and some immunocompromised people.The Centers for Disease Control and prevention is now recommending that certain immunocompromised individuals and people over the age of 50 who received an initial Moderna or Pfizer-BioNTech booster dose at least four months ago are now eligible for another shot of either vaccine.
"These updated recommendations acknowledge the increased risk of severe disease in certain populations including those who are elderly or over the age of 50 with multiple underlying conditions, along with the currently available data on vaccine and booster effectiveness," the agency said in a statement.version of the omicron variant, continues to spread in the U.S., and concern mounts that it could fuel another surge. BA.2 is now the dominant strain in the U.S., making up 54.
"Without protection against the omicron variant, particularly now we're confronting BA.2, there's a very high risk of hospitalization and death," he said. Administration officials said it's important to give people the option of a second booster as quickly as possible. The plan to offer it to people younger than 60 was made to ensure that more vulnerable people, particularly people of color who are more likely to suffer other health problems that put them at risk, also have the option of an additional booster.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Authorizes Fourth Pfizer and Moderna Covid Vaccine Doses for People Age 50 and OlderThe FDA made the decision comes without consulting its committee of independent vaccine experts.
Read more »
FDA OKs second Pfizer, Moderna COVID-19 booster for ages 50 and upU.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.
Read more »
FDA OKs another Pfizer, Moderna COVID booster for 50 and upU.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
Read more »
FDA OKs another Pfizer, Moderna COVID booster for 50 and upU.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
Read more »
FDA OKs another Pfizer, Moderna COVID booster for 50 and upU.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds. The Food and Drug Administration's decision opens a fourth dose of the Pfizer or Moderna vaccines to that age group at least four months after their previous booster. Until now, the FDA had cleared fourth doses only for people 12 and older who have severely weakened immune systems.
Read more »